| [Fire Fighting] Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire. | |
| [Ingestion] Seek medical attention. If individual is drowsy or unconscious, do not give anything by mouth; place individual on the left side with the head down. Contact a physician, medical facility, or poison control center for advice about whether to induce vomiting. If possible, do not leave individual unattended. | |
| [Inhalation] If symptoms develop, move individual away from exposure and into fresh air. If symptoms persist, seek medical attention. If breathing is difficult, administer oxygen. Keep person warm and quiet; seek immediate medical attention. | |
| [Skin] Flush skin with plenty of soap and water for at least 15 minutes while removing contaminated clothing and shoes. | |
| [Eyes] If symptoms develop, immediately move individual away from exposure and into fresh air. Flush eyes gently with water for at least 15 minutes while holding eyelids apart; seek immediate medical attention. | |
| [Storage] Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage. | |
| [Handling] All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood. | |
| [Inhalation] Respiratory failure occurred in animal studies following acute toxic doses. Pulmonary edema may result from abrupt reversal of opioid effects. | |
| [Ingestion] Nausea, vomiting, diarrhea, dry mouth and dyspepsia may occur following therapeutic or overdoses. | |
| [Personal Protection] Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots. | |
| [Respirators] Use NIOSH/MSHA approved respirator appropriate for exposure of concern. | |
| [Exposure Effects] Blood pressure may be increased (more probable) or decreased in the event of an overdose. Increased pulse rate may occur. Fever may occur. seizures resulting in death occurred in acute toxicity studies in animals. More common adverse effects of these agents include tremors, insomnia, dizziness, nervousness and anxiety. | |
| [Appearance] Crystals from acetone. | |
| [Solubility in water] 2038 mg/L | |
| [Melting Point] 168-170 | |
| [Vapor Pressure] 2.0e-16 | |
| [Partition Coefficient] .534 | |
| [Usage] Medication. | |
| [Product Name] 17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one | |
| [Synonyms] 17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one Celupan n-Cyclopropylmethyl-14-hydroxydihydromorphinone Trexan Um-792 | |
| [CAS] 16590-41-3 | |
| [Formula] C20H23NO4 | |
| [Molecular Weight] 341.41 | |
| [EINECS] 240-649-9 | |
| [RTECS] QD2155000 | |
| [RTECS Class] Drug; Mutagen; Reproductive Effector; Human Data | |
| [Merck] 12,6450 | |
| [Beilstein/Gmelin] 3596648 | |
| [Small spills/leaks] Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces. | |
| [Stability] No data. | |
| [Incompatibilities] Strong oxidizing agents. |
Print